华森制药：控股股东及其一致行动人减持致持股降至65%

Core Viewpoint - The announcement from Huason Pharmaceutical indicates a planned reduction in shareholding by major shareholders, which will not affect the company's control or trigger a mandatory bid [1] Shareholding Changes - The controlling shareholders, Chengdu Dajian, You Hongtao, and Tian Cheng Tian Li No. 1 Private Fund, collectively held 292 million shares, accounting for 70% of the total share capital before the reduction [1] - Chengdu Dajian reduced its holdings by 14.3732 million shares (3.44%), You Hongtao by 5.966 million shares (1.43%), and Tian Cheng Tian Li No. 1 Private Fund by 540,800 shares (0.13%) [1] - After the reduction, the total shareholding of these three parties decreased to 271 million shares, representing 65% of the total share capital [1]